Johnson & Johnson Announces Landmark Agreement to Enable its COVID-19 Vaccine to be Manufactured and Made Available by an African Company for People Living in Africa Read more
Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases Read more
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo (cemiplimab) Combination in NSCLC Read more
Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases Read more
Jardiance (empagliflozin) becomes the first and only approved treatment in Europe for adults with symptomatic chronic heart failure regardless of ejection fraction Read more
Teva Announces Launch of a First Generic Version of Revlimid (lenalidomide capsules), in the U.S. Read more
Adagene Announces SAFEbody Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates Read more